Source 1primary paper2025MED
Toolkit/next-generation sequencing of blood samples
next-generation sequencing of blood samples
Also known as: clinical metagenomics, metagenomic next-generation sequencing, NGS of blood samples
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Both vesicle fluid culture and next-generation sequencing (NGS) of blood samples confirmed the presence of Escherichia coli.
Usefulness & Problems
Why this is useful
Blood-sample NGS was used to confirm the presence of Escherichia coli in this severe atypical bullous erysipelas case. The abstract frames it as part of an early combined diagnostic approach with culture.; pathogen identification in immunosuppressed patients with severe skin infection; early combined microbial testing alongside culture
Source:
Blood-sample NGS was used to confirm the presence of Escherichia coli in this severe atypical bullous erysipelas case. The abstract frames it as part of an early combined diagnostic approach with culture.
Source:
pathogen identification in immunosuppressed patients with severe skin infection
Source:
early combined microbial testing alongside culture
Problem solved
It helps identify the causative microorganism in an immunosuppressed patient with rapidly progressive skin infection. In this case, pathogen confirmation supported de-escalation of antibiotic therapy.; supports confirmation of the pathogenic microorganism to guide antibiotic de-escalation
Source:
It helps identify the causative microorganism in an immunosuppressed patient with rapidly progressive skin infection. In this case, pathogen confirmation supported de-escalation of antibiotic therapy.
Source:
supports confirmation of the pathogenic microorganism to guide antibiotic de-escalation
Problem links
supports confirmation of the pathogenic microorganism to guide antibiotic de-escalation
LiteratureIt helps identify the causative microorganism in an immunosuppressed patient with rapidly progressive skin infection. In this case, pathogen confirmation supported de-escalation of antibiotic therapy.
Source:
It helps identify the causative microorganism in an immunosuppressed patient with rapidly progressive skin infection. In this case, pathogen confirmation supported de-escalation of antibiotic therapy.
Published Workflows
Objective: Diagnose the causative pathogen rapidly in a severe atypical bullous skin infection in an immunosuppressed patient and use that information to guide escalation then de-escalation of anti-infective therapy.
Why it works: The abstract states that early combined microbial culture and NGS can identify the pathogenic microorganism, enabling de-escalation within 24 hours of pathogen identification after initial broad-spectrum coverage.
combined lesion culture and blood-sample NGS for pathogen confirmationbroad-spectrum empiric coverage before identification followed by targeted de-escalation after identificationmicrobial culturenext-generation sequencingtiered anti-infective management
Stages
- 1.Early combined microbial testing(functional_characterization)
The abstract recommends early combined microbial culture and NGS testing so that the causative pathogen can be identified in rapidly progressive infection.
Selection: confirmation of the pathogenic microorganism using vesicle fluid culture and blood-sample NGS
- 2.Initial broad-spectrum anti-infective treatment(decision_gate)
The abstract states that a tiered anti-infective strategy is paramount, beginning with broad-spectrum coverage because severe infection can progress rapidly.
Selection: empiric coverage for both Gram-negative and Gram-positive bacteria in severe infection
- 3.De-escalation after pathogen confirmation(decision_gate)
The abstract recommends de-escalation within 24 hours of pathogen identification as part of the tiered anti-infective strategy.
Selection: pathogen identification confirming Escherichia coli
Steps
- 1.Obtain vesicle fluid culture and blood-sample NGSdiagnostic assays
Confirm the pathogenic microorganism in a rapidly progressive atypical bullous skin infection.
The abstract advises early combined microbial culture and NGS testing because the disease can progress to shock within 24 hours.
- 2.Escalate to broad-spectrum coverage for Gram-negative and Gram-positive bacteria
Provide immediate empiric anti-infective coverage during severe infection before targeted narrowing.
This occurs before pathogen-guided narrowing because the patient had rapidly progressive severe infection and initial cefuroxime treatment was ineffective.
- 3.De-escalate antibiotics within 24 hours of pathogen identification
Narrow therapy after confirmation of the causative microorganism.
The abstract states that de-escalation follows pathogen identification and should occur within 24 hours.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Mechanisms
sequence-based pathogen detectionTarget processes
No target processes tagged yet.
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
The method requires blood samples and sequencing-based pathogen detection capability. The source also presents it together with microbial culture as the recommended testing strategy.; requires blood sampling; is presented as complementary to microbial culture rather than a standalone replacement
Independent follow-up evidence is still limited. Validation breadth across biological contexts is still narrow. Independent reuse still looks limited, so the evidence base may be fragile.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Observations
successHuman Clinicaltherapeutic usehuman
Inferred from claim c1 during normalization. In this immunosuppressed patient with atypical bullous erysipelas, vesicle fluid culture and blood-sample NGS both confirmed Escherichia coli. Derived from claim c1.
Source:
Supporting Sources
Ranked Claims
In this immunosuppressed patient with atypical bullous erysipelas, vesicle fluid culture and blood-sample NGS both confirmed Escherichia coli.
For immunosuppressed patients with skin infections, early combined microbial culture and NGS testing with initial broad-spectrum coverage followed by de-escalation within 24 hours of pathogen identification is advisable.
de escalation timing after pathogen identification 24 hours
Approval Evidence
1 source2 linked approval claimsfirst-pass slug next-generation-sequencing-of-blood-samples
Both vesicle fluid culture and next-generation sequencing (NGS) of blood samples confirmed the presence of Escherichia coli.
Source:
case observationsupports
In this immunosuppressed patient with atypical bullous erysipelas, vesicle fluid culture and blood-sample NGS both confirmed Escherichia coli.
Source:
management recommendationsupports
For immunosuppressed patients with skin infections, early combined microbial culture and NGS testing with initial broad-spectrum coverage followed by de-escalation within 24 hours of pathogen identification is advisable.
Source:
Comparisons
Source-stated alternatives
The abstract explicitly mentions vesicle fluid culture as a paired diagnostic method. It also contrasts empiric antibiotic escalation before pathogen confirmation with targeted de-escalation after identification.
Source:
The abstract explicitly mentions vesicle fluid culture as a paired diagnostic method. It also contrasts empiric antibiotic escalation before pathogen confirmation with targeted de-escalation after identification.
Source-backed strengths
was used successfully in this case to confirm Escherichia coli from blood samples; is recommended in combination with microbial culture early in the course
Source:
was used successfully in this case to confirm Escherichia coli from blood samples
Source:
is recommended in combination with microbial culture early in the course
Compared with vesicle fluid culture
The abstract explicitly mentions vesicle fluid culture as a paired diagnostic method. It also contrasts empiric antibiotic escalation before pathogen confirmation with targeted de-escalation after identification.
Shared frame: source-stated alternative in extracted literature
Strengths here: was used successfully in this case to confirm Escherichia coli from blood samples; is recommended in combination with microbial culture early in the course.
Source:
The abstract explicitly mentions vesicle fluid culture as a paired diagnostic method. It also contrasts empiric antibiotic escalation before pathogen confirmation with targeted de-escalation after identification.
Ranked Citations
- 1.